From: COVID-19 infection: epidemiological, clinical, and radiological expression among adult population
All patients (240) | Non severe cases (n = 186) | Severe cases (n = 54) | P value | |
---|---|---|---|---|
Lesion laterality | 0.001 | |||
Unilateral lesions | 48 (20%) | 46 (95.8%) | 2 (4.2%) | |
Bilateral lesions | 188 (78.3%) | 136 (72.3%) | 52 (27.7%) | |
Free CT | 4 (1.7%) | 4 (100%) | 0 (0%) | |
Lesion location | < 0.000 | |||
Peripheral | 140 (58.3%) | 124 (88.6%) | 16 (11.4%) | |
Central | 8 (3.3%) | 8 (100.0%) | 0 (0%) | |
Both | 88 (36.7%) | 50 (56.8%) | 38 (43.2%) | |
Lesion distribution | < 0.000 | |||
Unilobar | 32 (13.3%) | 32 (100%) | 0 (0%) | |
Bilobar | 104 (43.3%) | 102 (98.1%) | 2 (1.9%) | |
Multilobar | 100 (41.7%) | 48 (48.0%) | 52 (52.0%) | |
Lesion pattern | ||||
GGO | 232 (96.7%) | 180 (77.6%) | 52 (22.4%) | < 0.000* |
Consolidation | 94 (39.2%) | 46 (48.9%) | 48 (51.1%) | 0.83* |
Septal lines | 44 (18.3%) | 36 (81.8%) | 8 (18.2%) | < 0.000* |
Crazy paving | 62 (25.8%5) | 54 (87.1%) | 8 (12.9%) | < 0.000* |
Special signs | ||||
Air bronchogram | 92 (38.3%) | 44 (47.8%) | 48 (52.2%) | 0.67* |
Reverse halo | 18 (7.5%) | 16 (88.9%) | 2 (11.1%) | 0.009* |
Vascular prominence | 28 (11.7%) | 14 (50.0%) | 14 (50.0%) | 1.00* |
White lung | 24 (10.0%) | 0 (0%) | 24 (100.0%) | ---------- |
Other findings | ||||
Lymphadenopathy | 36 (15.0%) | 22 (61.1%) | 14 (38.9%) | 0.19* |
Pleural effusion | 2 (0.8%) | 0 (0%) | 2 (100.0%) | ---------- |
CT score | ||||
Mean ± SD | 12.22 ± 6.02 | 9.56 ± 3.42 | 21.41 ± 3.34 | < 0.000# |
Mild (0–7) | 68 (28.3%) | |||
Moderate (8–15) | 118 (49.2%) | |||
Severe (16–25) | 54 (22.5) |